Tag: Pharma shares to buy

Nuvama on Godrej Consumer: Buy| Target price Rs 1,460| LTP Rs 1247| Upside 17%Nuvama has reiterated a Buy rating on Godrej Consumer Products Ltd (GCPL) with a target price of Rs 1,460, indicating a potential...
BENGALURU: Netherlands-based global tech investor Prosus invested over $8.6 billion in India, making it one of its strategic markets, CEO Fabricio Bloisi said in a letter to shareholders on Thursday.The update follows Swiggy's...

Pharma shares to buy: Necessary pill for portfolio during volatility and Trump tariff wars: 8 pharma stocks with an upside potential of up to...

SynopsisLet’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world...

Recent articles

spot_img